Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

Filing date Description Form Filing Group Filer View

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-19-000044.pdf 0001103021-19-000044.rtf 0001103021-19-000044.xls View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Davis Todd C 0001103021-19-000038.pdf 0001103021-19-000038.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Vollins James 0001103021-19-000039.pdf 0001103021-19-000039.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Plesha Scott M. 0001103021-19-000037.pdf 0001103021-19-000037.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Broadfin Capital, LLC 0000919574-19-007363.pdf 0000919574-19-007363.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001103021-19-000031.pdf 0001103021-19-000031.rtf 0001103021-19-000031.xls View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001103021-19-000033.pdf 0001103021-19-000033.rtf 0001103021-19-000033.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-19-000027.pdf 0001103021-19-000027.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
ODONNELL FRANCIS E JR 0001103021-19-000025.pdf 0001103021-19-000025.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0001103021-19-000023.pdf 0001103021-19-000023.rtf View HTML

Data provided by Kaleidoscope.

BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
Thank you. We will get back to you soon